Stinson wins EMD and Merck assignment

Share this article:
Stinson Brand Innovation was awarded a global strategy assignment from EMD Biosciences and Merck Biosciences. Stinson will provide brand alignment and strategic planning services for EMD, a major supplier of premium tools for proteomics and disease pathway analysis known through its global brands Calbiochem, Novabiochem and Novagen.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions